190 related articles for article (PubMed ID: 37221406)
1. Extensive cytokine biomarker analysis in serum of Guillain-Barré syndrome patients.
Li X; Yang L; Wang G; Yuan Y; Wei N; Yang W; Wang X; Wang Z
Sci Rep; 2023 May; 13(1):8354. PubMed ID: 37221406
[TBL] [Abstract][Full Text] [Related]
2. Altered serum levels of IL-36 cytokines (IL-36α, IL-36β, IL-36γ, and IL-36Ra) and their potential roles in Guillain-Barré syndrome.
Zhao Z; Zhang R; Gao X; Li H; Liu H
Medicine (Baltimore); 2020 Dec; 99(52):e23832. PubMed ID: 33350771
[TBL] [Abstract][Full Text] [Related]
3. Aberrated levels of cerebrospinal fluid chemokines in Guillain-Barré syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Press R; Pashenkov M; Jin JP; Link H
J Clin Immunol; 2003 Jul; 23(4):259-67. PubMed ID: 12959218
[TBL] [Abstract][Full Text] [Related]
4. The effects of IVIg therapy on serum levels of neuropeptide Y and cytokines in Guillain-Barré syndrome.
Li C; Luo T; Cheng Y; Liu S; Qiao L; Wu X; Liu K
Neurol Sci; 2020 Feb; 41(2):295-303. PubMed ID: 31494821
[TBL] [Abstract][Full Text] [Related]
5. Inferring immune-associated signatures based on a co-expression network in Guillain-Barré syndrome.
Zhang X; Zhang H; Liu Z; Guan R; Wang J; Kong X; Chen L; Bo C; Li J; Bai M; Lu X; Shen J; Wang L; Guo M
Cell Prolif; 2019 Jul; 52(4):e12634. PubMed ID: 31094043
[TBL] [Abstract][Full Text] [Related]
6. Interleukin 8, a Biomarker to Differentiate Guillain-Barré Syndrome From CIDP.
Breville G; Lascano AM; Roux-Lombard P; Vuilleumier N; Lalive PH
Neurol Neuroimmunol Neuroinflamm; 2021 Jul; 8(5):. PubMed ID: 34140310
[TBL] [Abstract][Full Text] [Related]
7. Bioinformatic analyses hinted at augmented T helper 17 cell differentiation and cytokine response as the central mechanism of COVID-19-associated Guillain-Barré syndrome.
Li Z; Huang Z; Li X; Huang C; Shen J; Li S; Zhang L; Wong SH; Chan MTV; Wu WKK
Cell Prolif; 2021 May; 54(5):e13024. PubMed ID: 33751722
[TBL] [Abstract][Full Text] [Related]
8. IL-10 and IFN-gamma in Guillain-Barré syndrome. Network Members of the Swedish Epidemiological Study Group.
Press R; Deretzi G; Zou LP; Zhu J; Fredman P; Lycke J; Link H
J Neuroimmunol; 2001 Jan; 112(1-2):129-38. PubMed ID: 11108941
[TBL] [Abstract][Full Text] [Related]
9. IL-35 Is Involved in the Pathogenesis of Guillain-Barré Syndrome Through Its Influence on the Function of CD4+ T Cells.
Liu H; Zhang W; Tian FF; Kun A; Zhou WB; Xiao B; Li J
Immunol Invest; 2015; 44(6):566-77. PubMed ID: 26225474
[TBL] [Abstract][Full Text] [Related]
10. Potential biomarkers identified by tandem mass tags based quantitative proteomics for diagnosis and classification of Guillain-Barré syndrome.
Ding Y; Shi Y; Wang L; Li G; Osman RA; Sun J; Qian L; Zheng G; Zhang G
Eur J Neurol; 2022 Apr; 29(4):1155-1164. PubMed ID: 34913222
[TBL] [Abstract][Full Text] [Related]
11. IL-17 and IL-22 in cerebrospinal fluid and plasma are elevated in Guillain-Barré syndrome.
Li S; Yu M; Li H; Zhang H; Jiang Y
Mediators Inflamm; 2012; 2012():260473. PubMed ID: 23091305
[TBL] [Abstract][Full Text] [Related]
12. Comprehensive cytokine profiling provides evidence for a multi-lineage Th responses in Guillain Barré Syndrome.
Debnath M; Nagappa M; Talukdar PM; Subbanna M; Sundaravadivel P; Shivakumar V; Dutta D; Wahatule R; Sinha S; Bindu PS; Periyavan S; Umamaheswara Rao GS; Taly AB
Cytokine; 2018 Oct; 110():58-62. PubMed ID: 29704819
[TBL] [Abstract][Full Text] [Related]
13. Guillain Barré Syndrome is induced in Non-Obese Diabetic (NOD) mice following Campylobacter jejuni infection and is exacerbated by antibiotics.
St Charles JL; Bell JA; Gadsden BJ; Malik A; Cooke H; Van de Grift LK; Kim HY; Smith EJ; Mansfield LS
J Autoimmun; 2017 Feb; 77():11-38. PubMed ID: 27939129
[TBL] [Abstract][Full Text] [Related]
14. Evidence of altered Th17 pathway signatures in the cerebrospinal fluid of patients with Guillain Barré Syndrome.
Debnath M; Nagappa M; Dutta D; Talukdar PM; Subbanna M; Shivakumar V; Wahatule R; Sinha S; Bindu PS; Periyavan S; Umamaheswara Rao GS; Kumar MA; Taly AB
J Clin Neurosci; 2020 May; 75():176-180. PubMed ID: 32217048
[TBL] [Abstract][Full Text] [Related]
15. Polymorphisms of IL-17 and ICAM-1 and their expression in Guillain-Barré syndrome.
Kharwar NK; Prasad KN; Singh K; Paliwal VK; Modi DR
Int J Neurosci; 2017 Aug; 127(8):680-687. PubMed ID: 27595159
[TBL] [Abstract][Full Text] [Related]
16. T cell reactivity to P0, P2, PMP-22, and myelin basic protein in patients with Guillain-Barre syndrome and chronic inflammatory demyelinating polyradiculoneuropathy.
Csurhes PA; Sullivan AA; Green K; Pender MP; McCombe PA
J Neurol Neurosurg Psychiatry; 2005 Oct; 76(10):1431-9. PubMed ID: 16170091
[TBL] [Abstract][Full Text] [Related]
17. Significance of serum antibody to GD1b ganglioside in patients with Guillain-Barré syndrome.
Reuben S; Mathai A; Sumi MG; Nair MD; Radhakrishnan VV
Indian J Med Res; 2001 Jun; 113():234-8. PubMed ID: 11816958
[TBL] [Abstract][Full Text] [Related]
18. Circulating Th17, Th22, and Th1 cells are elevated in the Guillain-Barré syndrome and downregulated by IVIg treatments.
Li S; Jin T; Zhang HL; Yu H; Meng F; Concha Quezada H; Zhu J
Mediators Inflamm; 2014; 2014():740947. PubMed ID: 24899787
[TBL] [Abstract][Full Text] [Related]
19. Gene Polymorphisms of Interleukin-27 Correlate with the Susceptibility, Severity, and Clinical Outcomes of Elderly People with Guillain-Barré Syndrome.
Zhang H; Zhao H; Yang G; Li Y; Liu Y
Gerontology; 2022; 68(8):854-860. PubMed ID: 34607327
[TBL] [Abstract][Full Text] [Related]
20. Case Report: Plasma Biomarkers Reflect Immune Mechanisms of Guillain-Barré Syndrome.
Wu CL; Chao CH; Lin SW; Chien YY; Huang WY; Weng WC; Su FC; Wei YC
Front Neurol; 2021; 12():720794. PubMed ID: 34539561
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
